Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: Results of randomized global phase III study 305

Epilepsia

Volumn 54, Issue 1, 2013, Pages 117-125

  French, Jacqueline A ^a   Krauss, Gregory L ^b   Steinhoff, Bernhard J ^c   Squillacote, David ^d   Yang, Haichen ^d   Kumar, Dinesh ^d   Laurenza, Antonio ^d  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Epilepsiezentrum Kork   (Germany)

^d EISAI INC   (United States)

Author keywords

Antiepileptic drugs; Epilepsy; Glutamate; LOCF analysis; Postsynaptic; Randomized controlled trials

Indexed keywords

PERAMPANEL; PLACEBO;

ADULT; AGED; ARTICLE; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; FOCAL EPILEPSY; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; TONIC CLONIC SEIZURE;

ADULT; ANTICONVULSANTS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EPILEPSIES, PARTIAL; FEMALE; HUMANS; MALE; PYRIDONES; TREATMENT OUTCOME;

EID: 84872090913     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2012.03638.x     Document Type: Article

References (12)

1. Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, Engel J, French J, Glauser TA, Mathern GW, Moshé SL, Nordli D, Plouin P, Scheffer IE,. (2010) Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 51: 676-685.
2. Chappell AS, Sander JW, Brodie MJ, Chadwick D, Lledo A, Zhang D, Bjerke J, Kiesler GM, Arroyo S,. (2002) A crossover, add-on trial of talampanel in patients with refractory partial seizures. Neurology 58: 1680-1682.
3. French JA, Abou-Khalil BW, Leroy RF, Yacubian EMT, Shin P, Hall S, Mansbach H, Nohria V,. (2011) Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy. Neurology 76: 1555-1563.
4. French J, Krauss GL, Biton V, Squillacote D, Yang H, Laurenza A, Kumar D, Rogawski MA,. (2012) Adjunctive perampanel for refractory partial-onset seizures: randomized Phase III study 304. Neurology 79: 589-596.
5. Gazzola DM, Balcer LJ, French JA,. (2007) Seizure-free outcome in randomized add-on trials of the new antiepileptic drugs. Epilepsia 48: 1303-1307.
6. Halász P, Kälviäinen R, Mazurkiewicz-Beldzinska M, Rosenow F, Doty P, Hebert D, Sullivan T,. (2009) Adjunctive lacosamide for partial-onset seizures: efficacy and safety results from a randomized controlled trial. Epilepsia 50: 443-453.
7. Hanada T, Hashizume Y, Tokuhara N, Takenaka O, Kohmura N, Ogasawara A, Hatakeyama S, Ohgoh M, Ueno M, Nishizawa Y,. (2011) Perampanel: a novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy. Epilepsia 52: 1331-1340.
8. ILAE. (1981) Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 22: 489-501.
9. Krauss GL, Bar M, Biton V, Klapper JA, Rektor I, Vaiciene-Magistris N, Squillacote D, Kumar D,. (2012a) Tolerability and safety of perampanel: two randomized dose-escalation studies. Acta Neurol Scand 125: 8-15.
10. Krauss GL, Serratosa JM, Villanueva VE, Endziniene M, Hong Z, French J, Yang H, Squillacote D, Edwards HB, Zhu J, Laurenza A,. (2012b) Randomized Phase III study 306: adjunctive perampanel for refractory partial-onset seizures. Neurology 78: 1408-1415.
11. Laurenza A, Ferry J, Hussein Z,. (2012) Population pharmacokinetics and pharmacodynamics of perampanel: a pooled analysis from three phase III trials. Epilepsy Curr 12 (Suppl. 1):abs 2.231.
12. Rogawski MA,. (2011) Revisiting AMPA receptors as an antiepileptic drug target. Epilepsy Curr 11: 56-63.